<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="utf-8">
<meta name="viewport" content="width=device-width,initial-scale=1">
<title>sphingolipids increases multicellular tumor spheroids vs 2D culture — pCite</title>
<link rel="stylesheet" href="../css/style.css">
</head>
<body>
<header>
  <h1><a href="../index.html">pCite</a></h1>
  <nav><a href="../index.html">Search</a><a href="../corpus.html">Corpus</a></nav>
</header>

<p class="section-label">CLAIM</p>
<hr class="section-rule">
<div class="triple">
  <strong>sphingolipids</strong>
  <span class="pred">&mdash;increases&rarr;</span>
  <strong>multicellular tumor spheroids vs 2D culture</strong>
</div>
<div class="entity-id">CHEBI:26739 &nbsp;&middot;&nbsp; UNKNOWN:HCT116 spheroid vs 2D</div>

<p class="section-label">VALIDATION</p>
<hr class="section-rule">
<div class="val-bar" style="--pct:5%;--color:#f0a030"></div>
<div class="stat-row">
  <span>Class: Curated (0.5)</span>
  <span>Replicated: 1 paper</span>
  <span>Score: 28.68<span class="score-tip"><span class="tip-icon">&nbsp;&#9432;</span><span class="tip-text">Score = &Sigma; incoming citation weights. Each citation is weighted by the validation class of the source claim (Physical 10.0 &middot; Curated 0.5 &middot; AI 0.01) multiplied by the citation type (Replicates 1.5 &middot; Supports 1.0 &middot; Contradicts 0.8). A score of 364 means this claim received strong physical-tier citation support.</span></span></span>
</div>

<p class="section-label">SCORE BREAKDOWN</p>
<hr class="section-rule">
<div class="score-breakdown">Base weight: 0.50 (Curated, 1 paper)<br>Score from 27 citations: <strong>28.68</strong><br><span style="color:#888">4&times; extends (+6.60) &middot; 16&times; supports (+19.14) &middot; 6&times; contradicts (+2.63) &middot; 1&times; applies (+0.30)</span></div>


<p class="section-label">EVIDENCE CHAIN &middot; 1 source</p>
<hr class="section-rule">
<div class="evidence-row"><span class="evidence-dot" style="background:#f0a030" title="Curated"></span><span>Curated</span><a href="https://doi.org/10.1002/jms.4880">10.1002/jms.4880</a></div>


<p class="section-label">CITATIONS RECEIVED &middot; 27 total</p>
<hr class="section-rule">
<div class="cite-bar"><span style="width:70px;text-align:right">Replicates</span><span class="cite-bar-fill" style="width:0px"></span><span>0</span></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Supports</span><span class="cite-bar-fill" style="width:100px"></span><span>16</span><span class="cite-subtotal">&middot; +19.14</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#ff7f0e"></span><span class="cite-claim-triple">phosphatidylethanolamines — is_biomarker_for → colorectal adenocarcinoma tissue</span><span class="cite-claim-weight">+4.00</span><a href="../claim/b159e4d0edb92c50.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#ff7f0e"></span><span class="cite-claim-triple">ceramides — is_biomarker_for → colorectal adenocarcinoma tissue</span><span class="cite-claim-weight">+4.64</span><a href="../claim/fbddabef2bccbbf8.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#ff7f0e"></span><span class="cite-claim-triple">Phosphatidylcholines (PCs) — is_biomarker_for → Colorectal Carcinoma</span><span class="cite-claim-weight">+4.00</span><a href="../claim/4d490d6332335a4a.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">lipid droplet-associated lipid subclasses — distinguishes → 3D spheroid vs 2D monolayer HCT116 colon carcinoma</span><span class="cite-claim-weight">+0.50</span><a href="../claim/090f00adbdc5f91f.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">polyunsaturated fatty acid-containing lipids — is_biomarker_for → colon cancer</span><span class="cite-claim-weight">+0.50</span><a href="../claim/7a0f9d8115912da9.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">TVB-2640 — causes → ferroptosis</span><span class="cite-claim-weight">+0.50</span><a href="../claim/b6fa066bd41ed25d.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">fatty acid synthase — is_biomarker_for → colorectal cancer</span><span class="cite-claim-weight">+0.50</span><a href="../claim/aaf78b637da92d78.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Lysophospholipids — is_biomarker_for → Colorectal Cancer</span><span class="cite-claim-weight">+0.50</span><a href="../claim/7be939a27b92bfa4.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Unsaturated fatty acids — is_biomarker_for → Colorectal Cancer</span><span class="cite-claim-weight">+0.50</span><a href="../claim/e0900715a00c585e.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Onvansertib — inhibits → Polo-like kinase 1</span><span class="cite-claim-weight">+0.50</span><a href="../claim/83072cab7aebf308.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Aurora kinase B — activates → Polo-like kinase 1</span><span class="cite-claim-weight">+0.50</span><a href="../claim/be5c6681b99c1a14.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Onvansertib — increases → Aurora kinase B</span><span class="cite-claim-weight">+0.50</span><a href="../claim/459495aa04e40056.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Onvansertib — increases → Borealin</span><span class="cite-claim-weight">+0.50</span><a href="../claim/a313c7e26180888a.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Onvansertib — causes → cell cycle arrest</span><span class="cite-claim-weight">+0.50</span><a href="../claim/b8a4eca4314d3241.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Onvansertib — treats → KRAS mutant colorectal cancer</span><span class="cite-claim-weight">+0.50</span><a href="../claim/252aa95765ca2eb0.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Polo-like kinase 1 — causes → resistance to doxorubicin</span><span class="cite-claim-weight">+0.50</span><a href="../claim/b58ce7b9f330f404.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Contradicts</span><span class="cite-bar-fill" style="width:38px"></span><span>6</span><span class="cite-subtotal">&middot; +2.63</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">cerulenin — decreases → polyunsaturated fatty acids</span><span class="cite-claim-weight">+0.40</span><a href="../claim/60d42d8e9d353e71.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">TVB-2640 — increases → polyunsaturated fatty acids</span><span class="cite-claim-weight">+0.40</span><a href="../claim/bb03509b27d901d8.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">TVB-2640 — inhibits → fatty acid synthase</span><span class="cite-claim-weight">+0.40</span><a href="../claim/53a79731e74dc97d.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Triacylglycerols — is_biomarker_for → Colorectal Cancer</span><span class="cite-claim-weight">+0.63</span><a href="../claim/91c7e117aa28d92a.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Onvansertib — increases → Phosphatidylcholine lipids</span><span class="cite-claim-weight">+0.40</span><a href="../claim/08968c17be7c4082.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Polo-like kinase 1 — is_biomarker_for → Colorectal cancer</span><span class="cite-claim-weight">+0.40</span><a href="../claim/9adb65473a00340c.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Extends</span><span class="cite-bar-fill" style="width:25px"></span><span>4</span><span class="cite-subtotal">&middot; +6.60</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">lipid droplet-associated lipid subclasses — increases → oxygen-restricted and acidic regions of spheroids</span><span class="cite-claim-weight">+0.60</span><a href="../claim/a524396fefbc3f24.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">polyunsaturated fatty acid-containing lipids — increases → quiescent and necrotic regions of spheroids</span><span class="cite-claim-weight">+0.60</span><a href="../claim/1ef569fee1ebdf0d.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#ff7f0e"></span><span class="cite-claim-triple">sphingolipids — is_biomarker_for → colon cancer</span><span class="cite-claim-weight">+4.80</span><a href="../claim/19f874501acc5676.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Onvansertib — increases → Onvansertib accumulation in spheroid</span><span class="cite-claim-weight">+0.60</span><a href="../claim/860639c63a0b0689.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Applies</span><span class="cite-bar-fill" style="width:6px"></span><span>1</span><span class="cite-subtotal">&middot; +0.30</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">cerulenin — inhibits → fatty acid synthase</span><span class="cite-claim-weight">+0.30</span><a href="../claim/ab36d3e5aa29f54f.html">view &rarr;</a></div>


<p class="section-label">IDENTIFIERS</p>
<hr class="section-rule">
<table class="id-table">
<tr><td>Claim ID</td><td><code>1610d5d8564c8610</code></td></tr>
<tr><td>Subject URI</td><td><a href="https://identifiers.org/CHEBI:26739">CHEBI:26739</a></td></tr>
<tr><td>Object URI</td><td><a href="https://identifiers.org/UNKNOWN:HCT116 spheroid vs 2D">UNKNOWN:HCT116 spheroid vs 2D</a></td></tr>
</table>
<footer>pCite — validation-weighted scientific claims</footer>
</body>
</html>
